61
association with the prognosis. Aii Zheng 2003 jan;22(1):86-90.
17- Matheus RS, Bernardi FDC, Gallo CP, da Silva AP, Rodrigues O R, Capelozzi M,
Lopes A, Fernezlian S, Saldiva PH, Capelozzi VL. - Nuclear Markers (Star 16-
Volume,mitotic index, AgNOR and Ki-67 ) of the primary tumour and its metastasis in nom-
small cell carcinoma. Pathol Res Pract 2004;200:13-23.
18- Mello FHM, Junqueira MS, Chammas R. - Mecanismos de invasão e metástases. Bases
da oncologia 2003 ;201-226.
19- Minamoto H, L Antonangelo, Gallo CP, Silva FBA , Fenezelian S, Silva AGP
,Rodrigues OR , Jatene FB, Saldiva PH, Capellozi VL. – Tumor cell and stromal features in
metastatic and non-metastatic non-small cell lung carcinomas. Histopathology 2003; 43 : 1-
17
20-Moldvay J, Scheid P, Wild P, Nabil K, Siat J, Borrelly J, Marie B, Farre G, Labib T,
Pottier G, Sesboue R, Bronner C, Vignaud JM, Martinet N. - Predictive Survival markers in
patients with surgically reseected nom-small cell lung carcinoma. Clin Cancer Res 2000
Mar; 6 (3):1125-1134.
21- Mountain CF. – Revisions in the International System for Staging Lung Cancer. Chest
1997; 111: 1710-1717.
22- Oliveira TB, Cury PM.- Câncer de Pulmão. HB Científica 2002 jan-abril (9).
23- Petty WJ, Dragnev KH, Dmitrovsky E. - Cyclin D1 as a target for chemoprevetion.
Lung cancer 2003; 41: S155-S161.
24- Pollan M,Varela G, Torres A, Torre ML, Ludena MD, Ortega MD, Pac J, Freixenet J,
Gomes G, Sebastian F, Dies M, Arrabal R, Canallis E, Tirado GJ, Arnedillo A, Ribas JJ,
Minguella J, Gomes A, Garcia M, Aragones N, Gomez PB, Abente GL, Sarmiento RG,
Rojas JM. – Cical Value of p53, c-erbB-2, CEA and CA 125 Regarding Relapse, Metastasis
and death in resectable nom-small cell lung cancer. Int J Cancer 2003; 107:781-790.
25- Ratschiller D,Heighway J,Gugger M,Kappeler A,Pirnia F,Schmid RA,Borner MM,